BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32971479
Number of visits today
8348
Number of downloads
16137127
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Kahremany S, Hofmann L, Gruzman A, Dinkova-Kostova AT, Cohen G. NRF2 in dermatological disorders: Pharmacological activation for protection against cutaneous photodamage and photodermatosis. Free Radic Biol Med 2022;188:262-76. [PMID: 35753587 DOI: 10.1016/j.freeradbiomed.2022.06.238] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Cuadrado A, Dinkova-Kostova AT, Mann GE. Introduction to Special Issue on "Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases". Free Radic Biol Med 2023;195:258-60. [PMID: 36586454 DOI: 10.1016/j.freeradbiomed.2022.12.100] [Reference Citation Analysis]
2 Cohen D, Portugal‐cohen M, Oron M, Frusic‐zlotkin M, Soroka Y, Ma'or Z, Amar D, Kohen R. Cutaneous Nrf2‐Keap1 pathway modulation by environmental factors: The Dead Sea area as a test case. BioFactors 2022. [DOI: 10.1002/biof.1926] [Reference Citation Analysis]
3 Steinhoff M, Alam M, Ahmad A, Uddin S, Buddenkotte J. Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes. Semin Cancer Biol 2022;87:98-116. [PMID: 36372325 DOI: 10.1016/j.semcancer.2022.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Panieri E, Telkoparan‐akillilar P, Saso L. NRF2 , a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer. BioFactors 2022. [DOI: 10.1002/biof.1912] [Reference Citation Analysis]
5 Rasheed M, Butt DMG, Izhar Q, Rasheed M. Personality Construct Among Patients With Substance Use Disorder: An Explanatory Study In Pakistan. IJIST 2022;4:42-49. [DOI: 10.33411/ijist/2022040613] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345